24
Oct
2023

Chongqing Kangle Pharmaceutical CO.,LTD

Exhibitor at CPHI Barcelona 2023 stand 7A59, API
About Us

Chongqing Kangle Pharmaceutical Co Ltd was established in 1988, and is owned by Beijing Unisplendour Pharmaceutical Co Ltd. Kangle is an FDA approved company which is specialized in producing APIs and intermediates via synthesis method.
Our main products are:- Cilostazol, Hydroxychloroquine sulfate, Piperaquine phosphate,Chloroquine phosphate, Sulfadoxine, Sulfadiazine and Rocuronium bromide intermediate.
Our company is the world's largest anti-malaria drugs API professional manufacturer. We are looking forward to cooperating with you for the brighter future.

  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 7A59, API

Products Featured at CPHI Barcelona 2023

  • Cilostazol(FDA Approved) (Micronized)

    Product Cilostazol(FDA Approved) (Micronized)

    Chongqing Kangle Pharmaceutical Co. Ltd. provides wide range of pharmaceutical products which includes cilostazol(fda approved) (micronized). It belongs to active pharmaceutical ingredients category. Properties: white to similar to white crystal or crystalline powder. Use: cardiovascular drug. Contact us f...